Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1973 1
1974 1
1975 1
1977 1
1978 3
1979 1
1980 2
1981 2
1982 2
1983 3
1984 2
1985 1
1986 4
1989 3
1990 3
1991 1
1992 4
1993 2
1994 5
1995 4
1996 8
1997 1
1998 2
1999 3
2000 6
2001 6
2002 5
2003 9
2004 4
2005 4
2006 5
2007 8
2008 5
2009 6
2010 4
2011 3
2012 2
2013 2
2014 6
2015 5
2016 1
2017 8
2018 4
2019 9
2020 7
2021 9
2022 15
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "In Utero Drug Withdrawal"
Page 1
Family planning considerations in people with multiple sclerosis.
Krysko KM, Dobson R, Alroughani R, Amato MP, Bove R, Ciplea AI, Fragoso Y, Houtchens M, Jokubaitis VG, Magyari M, Abdelnasser A, Padma V, Thiel S, Tintore M, Vukusic S, Hellwig K. Krysko KM, et al. Lancet Neurol. 2023 Apr;22(4):350-366. doi: 10.1016/S1474-4422(22)00426-4. Lancet Neurol. 2023. PMID: 36931808 Review.
Drug labels are typically restrictive and favour fetal safety over maternal safety. Emerging data reporting outcomes in neonates exposed to DMTs in utero and through breastfeeding will allow for more careful and individualised treatment decisions. ...
Drug labels are typically restrictive and favour fetal safety over maternal safety. Emerging data reporting outcomes in neonates expo …
Evidence-Based Contraception: Common Questions and Answers.
Paradise SL, Landis CA, Klein DA. Paradise SL, et al. Am Fam Physician. 2022 Sep;106(3):251-259. Am Fam Physician. 2022. PMID: 36126006
One levonorgestrel-releasing intrauterine device, 52 mg, (Mirena) was recently approved by the U.S. Food and Drug Administration (FDA) for seven years of use to prevent pregnancy. ...Testosterone does not prevent pregnancy but is safe to use with hormonal contraception; th …
One levonorgestrel-releasing intrauterine device, 52 mg, (Mirena) was recently approved by the U.S. Food and Drug Administration (FDA …
Prenatal Opioid Exposure and Neurodevelopmental Outcomes.
Lee JJ, Saraiya N, Kuzniewicz MW. Lee JJ, et al. J Neurosurg Anesthesiol. 2023 Jan 1;35(1):142-146. doi: 10.1097/ANA.0000000000000876. Epub 2022 Dec 6. J Neurosurg Anesthesiol. 2023. PMID: 36745179 Review.
The opioid epidemic in the United States has resulted in a significant increase in opioid use disorder among pregnant women and a concomitant increase in the incidence of neonatal opioid withdrawal syndrome. The long-term consequences of prenatal opioid exposure on neurode …
The opioid epidemic in the United States has resulted in a significant increase in opioid use disorder among pregnant women and a concomitan …
The placenta as a target of opioid drugs†.
Rosenfeld CS. Rosenfeld CS. Biol Reprod. 2022 Apr 26;106(4):676-686. doi: 10.1093/biolre/ioac003. Biol Reprod. 2022. PMID: 35024817 Free PMC article. Review.
Neonates born to these women are at risk for neonatal abstinence syndrome (also referred to as neonatal opioid withdrawal syndrome). Negative birth outcomes linked with maternal opioid use disorder include compromised fetal growth, premature birth, reduced birthweight, and …
Neonates born to these women are at risk for neonatal abstinence syndrome (also referred to as neonatal opioid withdrawal syndrome). …
Duration and Timing of In Utero Opioid Exposure and Incidence of Neonatal Withdrawal Syndrome.
Wang Y, Berger L, Durrance C, Kirby RS, Kuo D, Pac J, Ehrenthal DB. Wang Y, et al. Obstet Gynecol. 2023 Sep 1;142(3):603-611. doi: 10.1097/AOG.0000000000005289. Obstet Gynecol. 2023. PMID: 37548391
OBJECTIVE: To evaluate the association between prenatal prescription opioid analgesic exposure (duration, timing) and neonatal opioid withdrawal syndrome (NOWS). METHODS: We conducted a retrospective cohort study of Wisconsin Medicaid-covered singleton live births from 201 …
OBJECTIVE: To evaluate the association between prenatal prescription opioid analgesic exposure (duration, timing) and neonatal opioid wit …
Tibolone: a review.
Albertazzi P, Di Micco R, Zanardi E. Albertazzi P, et al. Maturitas. 1998 Nov 16;30(3):295-305. doi: 10.1016/s0378-5122(98)00059-0. Maturitas. 1998. PMID: 9881330 Review.
Tibolone appears to be at least as efficacious as other forms of hormonal replacement therapy (HRT) on climacteric symptoms. It does not cause withdrawal bleeding when used in women with at least 1 year of amenorrhea. ...
Tibolone appears to be at least as efficacious as other forms of hormonal replacement therapy (HRT) on climacteric symptoms. It does not cau …
Neonatal Abstinence Syndrome Management: A Review of Recent Evidence.
Grossman M, Seashore C, Holmes AV. Grossman M, et al. Rev Recent Clin Trials. 2017;12(4):226-232. doi: 10.2174/1574887112666170816144818. Rev Recent Clin Trials. 2017. PMID: 28814260 Review.
BACKGROUND: The evaluation and management of infants with neonatal abstinence syndrome (NAS), the constellation of opioid withdrawal specific to newborns, have received renewed attention over the past decade during a new epidemic of opioid use, misuse, abuse, and dependenc …
BACKGROUND: The evaluation and management of infants with neonatal abstinence syndrome (NAS), the constellation of opioid withdrawal …
The importance of monotherapy in pregnancy.
Pennell PB. Pennell PB. Neurology. 2003 Jun 10;60(11 Suppl 4):S31-8. doi: 10.1212/wnl.60.11_suppl_4.s31. Neurology. 2003. PMID: 12796519 Review.
The most common major malformations are cleft lip/palate, heart defects, neural tube defects, and urogenital defects. Although AEDs have teratogenic risks, withdrawal of all AEDs before pregnancy is not a realistic option for many women with epilepsy. The results of severa …
The most common major malformations are cleft lip/palate, heart defects, neural tube defects, and urogenital defects. Although AEDs have ter …
The role and use of progestogens.
Whitehead MI, Hillard TC, Crook D. Whitehead MI, et al. Obstet Gynecol. 1990 Apr;75(4 Suppl):59S-76S; discussion 81S-83S. Obstet Gynecol. 1990. PMID: 2179792 Review.
In addition, most women taking cyclic progestogens experience regular withdrawal bleeding. Continuous/combined therapy has been introduced to minimize these side effects and induce amenorrhea. ...
In addition, most women taking cyclic progestogens experience regular withdrawal bleeding. Continuous/combined therapy has been intro …
190 results